Epitomee Medical is pursuing strategic global distribution rights with Nestle and requires FDA approval for its products, which are listed on the Tel Aviv Stock Exchange.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Epitomee Medical is pursuing strategic global distribution rights with Nestle and requires FDA approval for its products, which are listed on the Tel Aviv Stock Exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tel Aviv Stock Exchange
stock exchange located in Tel Aviv, Israel